NYSE:AVNS Avanos Medical Q1 2026 Earnings Results & Report $24.99 0.00 (0.00%) As of 10/9/2026 Avanos Medical beat analyst expectations on both earnings and revenue in its Q1 2026 results, released May 5, 2026. The company reported EPS of $0.22 versus the $0.16 consensus estimate, while revenue of $182.20 million topped the $170.00 million estimate by $12.20 million. Revenue increased 8.8% year over year. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateMay 5, 2026TimeBefore Market OpensConference Call4:00 PM ET Avanos Medical EPS ResultsActual EPS$0.22Consensus EPS $0.16Beat/MissBeat by +$0.06One Year Ago EPS$0.26EPS Beat Rate6 of last 8 quartersAvanos Medical Revenue ResultsActual Revenue$182.20 millionExpected Revenue$170.00 millionBeat/MissBeat by +$12.20 millionYoY Revenue Growth+8.80%Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Avanos Medical Q1 2026 Earnings FAQ Did Avanos Medical beat earnings estimates for Q1 2026? Avanos Medical (NYSE:AVNS) reported earnings of $0.22 per share for Q1 2026, beating the consensus estimate of $0.16. The report was announced on Tuesday, May 5, 2026. What was Avanos Medical's revenue for Q1 2026? Avanos Medical reported revenue of $182.20 million for Q1 2026, against a consensus estimate of $170.00 million. Avanos Medical Earnings HeadlinesSterlington Advises Avanos Medical Management Team on $1.27 Billion AcquisitionJuly 29, 2026 | businesswire.comAvanos Medical, Inc. Stockholders Approve Acquisition by American Industrial PartnersJuly 22, 2026 | prnewswire.comWhat’s Elon building now?New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.October 10 at 1:00 AM | Paradigm Press (Ad)Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending MergerJuly 2, 2026 | prnewswire.comAvanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNSJune 24, 2026 | businesswire.comA Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price SurgeJune 4, 2026 | finance.yahoo.comSee More Avanos Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Avanos Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avanos Medical and other key companies, straight to your email. Email Address About Avanos MedicalAvanos Medical (NYSE:AVNS) is a medical device company that develops and commercializes products designed to improve patient outcomes and reduce the use of opioids and other invasive interventions. The company focuses primarily on pain management and patient care, serving healthcare providers in hospitals, outpatient facilities and other clinical settings. Its pain management portfolio includes interventional products such as COOLIEF radiofrequency ablation systems, ON-Q pain relief systems and related infusion technologies. These products are intended to provide targeted, non-opioid or opioid-sparing pain relief for patients recovering from surgery or undergoing treatment for chronic pain. Avanos also offers products for digestive health and enteral feeding, including feeding tubes, accessories and systems used to deliver nutrition and medication to patients who cannot eat normally. The company markets its products internationally through direct sales and distribution networks, serving healthcare markets in the United States and other countries. The company was formed after Kimberly-Clark separated its healthcare business in 2014 under the Halyard Health name. Halyard Health adopted the Avanos name in 2018 as part of its continued focus on medical devices and patient-care solutions.View Avanos Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
